Stefania Mantovani

Dr. Stefania Mantovani

Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2020 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
SVStefania Varchetta
Stefania Varchetta
DMDalila Mele
Dalila Mele
BOBarbara Oliviero
Barbara Oliviero
SMStefania Mantovani
Stefania Mantovani
SLSerena Ludovisi
Serena Ludovisi
Mario MondelliMario Mondelli
Mario Mondelli
The relationship between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and host immunity is poorly understood. We performed an extensive analysis of immune responses in 32 patients with severe COVID-19, some of whom succumbed. A control population of healthy subjects was included. Patients with COVID-19 had an altered distribution of peripheral blood lymphocytes, with an increased proportion of mature natural killer (NK) cells and low T-cell numbers. NK cells and CD8+T cells overexpressed T-cell immunoglobulin and mucin domain-3 (TIM-3) and CD69. NK cell exhaustion was attested by increased frequencies of programmed cell death protein 1 (PD-1) positive cells and reduced frequencies of natural killer group 2 member D (NKG2D)-, DNAX accessory molecule-1 (DNAM-1)- and sialic acid-binding Ig-like lectin 7 (Siglec-7)-expressing NK cells, associated with a reduced ability to secrete interferon (IFN)γ. Patients with poor outcome showed a contraction of immature CD56brightand an expansion of mature CD57+FcεRIγnegadaptive NK cells compared to survivors. Increased serum levels of IL-6 were also more frequently identified in deceased patients compared to survivors. Of note, monocytes secreted abundant quantities of IL-6, IL-8, and IL-1β which persisted at lower levels several weeks after recovery with concomitant normalization of CD69, PD-1 and TIM-3 expression and restoration of CD8+T cell numbers. A hyperactivated/exhausted immune response dominate in severe SARS-CoV-2 infection, probably driven by an uncontrolled secretion of inflammatory cytokines by monocytes. These findings unveil a unique immunological profile in COVID-19 patients that will help to design effective stage-specific treatments for this potentially deadly disease.

2 March 2021 in eLife
Verified
Journal Article
Open access
CFChiara Fallerini
Chiara Fallerini
SDSergio Daga
Sergio Daga
SMStefania Mantovani
Stefania Mantovani
EBElisa Benetti
Elisa Benetti
NPnicola picchiotti
nicola picchiotti
EFElisa Frullanti
Elisa Frullanti
Background: Recently, loss-of-function variants in TLR7 were identified in two families in which COVID-19 segregates like an X-linked recessive disorder environmentally conditioned by SARS-CoV-2. We investigated whether the two families represent the tip of the iceberg of a subset of COVID-19 male patients.Methods: This is a nested case-control study in which we compared male participants with extreme phenotype selected from the Italian GEN-COVID cohort of SARS-CoV-2-infected participants (<60 y, 79 severe cases versus 77 control cases). We applied the LASSO Logistic Regression analysis, considering only rare variants on young male subsets with extreme phenotype, picking up TLR7 as the most important susceptibility gene.Results: Overall, we found TLR7 deleterious variants in 2.1% of severely affected males and in none of the asymptomatic participants. The functional gene expression profile analysis demonstrated a reduction in TLR7-related gene expression in patients compared with controls demonstrating an impairment in type I and II IFN responses.Conclusions: Young males with TLR7 loss-of-function variants and severe COVID-19 represent a subset of male patients contributing to disease susceptibility in up to 2% of severe COVID-19.Funding: Funded by private donors for the Host Genetics Research Project, the Intesa San Paolo for 2020 charity fund, and the Host Genetics Initiative.Clinical trial number: NCT04549831.

1 August 2001 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
BPBelinda Palermo
Belinda Palermo
RCRita Campanelli
Rita Campanelli
SGSilvia Garbelli
Silvia Garbelli
SMStefania Mantovani
Stefania Mantovani
ELErica Lantelme
Erica Lantelme
Claudia GiachinoClaudia Giachino
Claudia Giachino

1 May 2009 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
SMStefania Mantovani
Stefania Mantovani
SGSilvia Garbelli
Silvia Garbelli
APAlessandra Pasini
Alessandra Pasini
DADario Alimonti
Dario Alimonti
CPCesare Perotti
Cesare Perotti
GMGabriele Mora
Gabriele Mora

5 October 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Giovanni NARDOGiovanni NARDO
Giovanni NARDO
SPSilvia Pozzi
Silvia Pozzi
MPMauro Pignataro
Mauro Pignataro
ELEliana Lauranzano
Eliana Lauranzano
GSGiorgia Spano
Giorgia Spano
VBValentina Bonetto
Valentina Bonetto
Amyotrophic lateral sclerosis (ALS) is a fatal progressive motor neuron disease, for which there are still no diagnostic/prognostic test and therapy. Specific molecular biomarkers are urgently needed to facilitate clinical studies and speed up the development of effective treatments. We used a two-dimensional difference in gel electrophoresis approach to identify in easily accessible clinical samples, peripheral blood mononuclear cells (PBMC), a panel of protein biomarkers that are closely associated with ALS. Validations and a longitudinal study were performed by immunoassays on a selected number of proteins. The same proteins were also measured in PBMC and spinal cord of a G93A SOD1 transgenic rat model. We identified combinations of protein biomarkers that can distinguish, with high discriminatory power, ALS patients from healthy controls (98%), and from patients with neurological disorders that may resemble ALS (91%), between two levels of disease severity (90%), and a number of translational biomarkers, that link responses between human and animal model. We demonstrated that TDP-43, cyclophilin A and ERp57 associate with disease progression in a longitudinal study. Moreover, the protein profile changes detected in peripheral blood mononuclear cells of ALS patients are suggestive of possible intracellular pathogenic mechanisms such as endoplasmic reticulum stress, nitrative stress, disturbances in redox regulation and RNA processing. Our results indicate that PBMC multiprotein biomarkers could contribute to determine amyotrophic lateral sclerosis diagnosis, differential diagnosis, disease severity and progression, and may help to elucidate pathogenic mechanisms.

2 September 2020 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
BOBarbara Oliviero
Barbara Oliviero
SVStefania Varchetta
Stefania Varchetta
DMDalila Mele
Dalila Mele
SMStefania Mantovani
Stefania Mantovani
ACAntonella Cerino
Antonella Cerino
Mario MondelliMario Mondelli
Mario Mondelli